Craig C. Hopkinson - Feb 23, 2022 Form 4 Insider Report for Alkermes plc. (ALKS)

Role
EVP R&D, Chief Medical Officer
Signature
/s/ Stephanie Roche, attorney-in-fact for Craig C. Hopkinson
Stock symbol
ALKS
Transactions as of
Feb 23, 2022
Transactions value $
-$296,650
Form type
4
Date filed
2/24/2022, 04:34 PM
Previous filing
Feb 23, 2022
Next filing
Dec 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALKS Ordinary Shares Sale -$297K -12K -39.97% $24.76 18K Feb 23, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 The price reported in Column 4 of Table I is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.58 to $25.03. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.